Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Appointed director Quarterly results
|
Axogen, Inc. (AXGN)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/07/2023 |
8-K
| Quarterly results |
05/09/2023 |
8-K
| Quarterly results |
11/08/2022 |
8-K
| Investor presentation, Quarterly results |
08/03/2022 |
8-K
| Quarterly results |
05/04/2022 |
8-K
| Quarterly results |
11/03/2021 |
8-K
| Quarterly results |
08/04/2021 |
8-K
| Quarterly results |
05/05/2021 |
8-K
| Quarterly results |
10/29/2020 |
8-K
| Quarterly results |
08/05/2020 |
8-K
| Quarterly results |
05/06/2020 |
8-K
| Quarterly results |
11/06/2019 |
8-K
| Quarterly results |
08/06/2019 |
8-K
| Quarterly results |
05/08/2019 |
8-K
| Quarterly results |
10/29/2018 |
8-K
| Quarterly results
Docs:
|
"Agreement of Lease dated October 26, 2018, by and between Ashley Avenue Associates I, LLC and AxoGen Corporation",
"EXECUTIVE EMPLOYMENT AGREEMENT",
"AXOGEN, INC. INCENTIVE STOCK OPTION AGREEMENT",
"On or after each of the following dates Percentage of Units vested per corresponding date",
"AMENDMENT NO. 4 TO EMPLOYMENT AGREEMENT",
"EXECUTIVE EMPLOYMENT AGREEMENT",
"AxoGen, Inc. Reports 2018 Third Quarter Financial Results Q3 Revenue of $22.7 million, representing 41% growth over prior year; Management reiterates full year 2018 guidance and introduces 2019 guidance" |
|
08/01/2018 |
8-K
| Quarterly results |
02/28/2018 |
8-K
| Quarterly results |
11/01/2017 |
8-K
| Quarterly results |
08/02/2017 |
8-K
| Quarterly results |
05/04/2017 |
8-K
| Form 8-K - Current report |
02/22/2017 |
8-K
| Form 8-K - Current report |
11/02/2016 |
8-K
| Form 8-K - Current report |
08/03/2016 |
8-K
| Form 8-K - Current report |
05/04/2016 |
8-K
| Form 8-K - Current report |
11/13/2014 |
8-K
| Quarterly results
Docs:
|
"Opinion of Kaplan, Strangis and Kaplan, P.A regarding the sale of common stock to Three Peaks.",
"Opinion of Opinion of Kaplan, Strangis and Kaplan, P.A regarding the sale of common stock to PDL",
"December 31, 2013 Assets Current assets: Cash and cash equivalents $ 11,802,608 $ 20,069,750 Accounts receivable 2,743,041 1,893,699 Inventory 3,346,115 3,398,438 Prepaid expenses and other 100,923 296,719 Total current assets 17,992,687 25,658,606 Property and equipment, net 613,174 381,689 Intangible assets 576,382 570,396 Deferred financing costs 914,931 1,073,579 $ 20,097,174 $ 27,684,270 Liabilities and Shareholders' Equity Current liabilities: Accounts payable and accrued expenses $ 2,020,091 $ 2,083,942 Current deferred revenue 14,118 14,118 Total current liabilities 2,034,209 2,098,060 Note Payable - Revenue Interest Purchase Agreement 28,173,877 25,363,695 Long Term Deferred Revenue 75,168 85,882 Total liabilities 30,283,254 27,547,637 Commitments and contingencies — — Shareholder...",
"AxoGen, Inc. Lee Robert “Bob” Johnston, Chief Financial Officer 386.462.6856 [email protected] EVC Group Bob Jones/Michael Polyviou — Investor Relations 646.201.5447/212.850.6020 [email protected]; [email protected]" |
|
08/05/2014 |
8-K
| Quarterly results |
04/30/2014 |
8-K
| Quarterly results |
03/06/2014 |
8-K
| Quarterly results |
10/31/2013 |
8-K
| Quarterly results |
07/11/2013 |
8-K
| Quarterly results |
05/01/2013 |
8-K
| Quarterly results |
11/09/2012 |
8-K
| Form 8-K - Current report |
05/15/2012 |
8-K
| Form 8-K - Current report |
11/10/2011 |
8-K
| Form 8-K - Current report |
|
|